Reaction

Erythema Of Eyelid reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,276 reports · 55 co-occurring drugs

As of the last recalculation, Erythema Of Eyelid appears in 5,276 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is BIMATOPROST (PRR 171.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Bimatoprost	1,014	171.6	177.9
Cenegermin-Bkbj	117	39.0	39.4
Dorzolamide Hydrochloride And Timolol Maleate	50	25.2	25.3
Carboxymethylcellulose Sodium	57	24.2	24.3
Brimonidine Tartrate	98	22.1	22.2
Timolol Maleate	46	18.5	18.6
Lifitegrast	66	16.1	16.2
Travoprost	30	13.8	13.8
Latanoprost	145	11.7	11.7
Cyclosporine	293	10.9	11.0
Brinzolamide	23	10.5	10.5
Dupilumab	1,001	9.9	9.9
Tobramycin Solution	29	9.6	9.6
Tobramycin Sulfate	29	9.3	9.3
Timolol	23	7.5	7.6
Prednisolone Acetate	19	7.3	7.3
Moxifloxacin	24	6.7	6.8
Moxifloxacin Hydrochloride	33	6.5	6.5
Tobramycin	38	6.3	6.3
Triamcinolone Acetonide Ointment Usp, 0.05%	35	5.9	5.9
Erythromycin	27	5.7	5.7
Botulinum Toxin Type A	17	5.4	5.4
Iohexol	11	5.2	5.2
Mometasone	21	4.5	4.5
Triamcinolone Acetonide	35	4.5	4.5
Azelastine	19	4.2	4.2
Thyroid, Porcine	10	3.7	3.7
Lamotrigine	116	3.5	3.5
Hydroxyzine Hydrochloride	11	3.3	3.3
Hydroxyzine Hydrochloride Oral	11	3.3	3.3
Liothyronine Sodium	7	3.2	3.2
Clobetasol Propionate Ointment Usp, 0.05%	8	3.1	3.1
Clobetasol Propionate	8	3.1	3.1
Fish Oil	68	3.0	3.0
Sulfur	6	2.8	2.8
Gentamicin Sulfate	11	2.8	2.8
Niacin	8	2.7	2.7
Ketoconazole Foam	10	2.7	2.7
Ketoconazole Cream, 2%	10	2.7	2.7
Cetirizine Hcl	6	2.6	2.6
Fexofenadine Hydrochloride	14	2.5	2.5
Biotin	20	2.5	2.5
Adapalene	115	2.5	2.5
Nebivolol	10	2.5	2.5
Crisaborole	6	2.5	2.5
Levocetirizine Dihydrochloride	15	2.5	2.5
Onabotulinumtoxina	47	2.4	2.4
Ranibizumab	14	2.1	2.1
Dexlansoprazole	20	1.9	1.9
Salicylic Acid	24	1.8	1.8
Panitumumab	7	1.8	1.8
Nemolizumab-Ilto	4	1.2	1.2
Aflibercept	9	1.1	1.1
Fremanezumab-Vfrm	3	1.0	1.0
Minoxidil	7	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.